Last reviewed · How we verify

NCT02950181: NIRSCI

Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients

Terminated NA Last updated 28 May 2020
What this trial tests

NA trial testing NIRS in Stroke in 299 participants. Terminated before completion.

Timeline
29 July 2014
Primary endpoint
1 January 2019
1 January 2019

Quick facts

Lead sponsorArkansas Children's Hospital Research Institute
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment299
Start date29 July 2014
Primary completion1 January 2019
Estimated completion1 January 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Arkansas Children's Hospital Research Institute

Who can join

Adults 1 Day to 21, any sex, with Stroke or Diabetic Ketoacidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study involves looking at Cerebral oximetry measurements in pediatric and neonatal patients who are experiencing a critical illness. Such as Altered mental status, seizures, trauma, sepsis, etc.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of NIRS

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Arkansas Children's Hospital Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02950181.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing